Literature DB >> 26019428

Encephalitis due to antibodies to voltage gated potassium channel (VGKC) with cerebellar involvement in a teenager.

Megan M Langille1, Jay Desai1.   

Abstract

Encephalitis due to antibodies to voltage gated potassium channel (VGKC) typically presents with limbic encephalitis and medial temporal lobe involvement on neuroimaging. We describe a case of 13 year girl female with encephalitis due to antibodies to VGKC with signal changes in the cerebellar dentate nuclei bilaterally and clinical features that suggested predominant cerebellar involvement. These have never been reported previously in the literature. Our case expands the phenotypic spectrum of this rare condition.

Entities:  

Keywords:  Antibodies to voltage gated potassium channel; VGKC; anti-VGKC; encephalitis; voltage gated potassium channel

Year:  2015        PMID: 26019428      PMCID: PMC4445206          DOI: 10.4103/0972-2327.150623

Source DB:  PubMed          Journal:  Ann Indian Acad Neurol        ISSN: 0972-2327            Impact factor:   1.383


Case Summary

A 13 year old previously healthy and developmentally normal female presented with 3 days of fatigue and muscle aches. One day prior to admission to our institution, she developed unsteadiness and inability to walk. This was followed by alteration of sensorium that progressed to stupor and bilateral 6th nerve palsies. Magnetic resonance imaging (MRI) of brain showed hyperintensities involving the dentate nuclei bilaterally [Figure 1]. She had no clinical seizures and electroencephalograms on multiple occasions failed to reveal epileptiform discharges or electrographic seizures. Extensive infectious and rheumatological work-up was negative. Antibodies to voltage gated potassium channel (VGKC) were positive and elevated at 0.05 nanomole per liter in serum (normal < or = to 0.02). Paraneoplastic work up was otherwise negative including extensive search for an occult malignancy. She received corticosteroids, intravenous immunoglobulin, and rituximab. Her sensorium improved gradually and mental status returned to baseline. She had significant dysarthria, truncal and gait ataxia, dysmetria, and nystagmus. Although these cerebellar signs improved, she was left with residual deficits. Repeat MRI showed resolution of the previously seen signal changes in the dentate nuclei [Figure 2].
Figure 1

(a and b) Signal changes involving the dentate nuclei bilaterally

Figure 2

(a and b) Resolution of the signal changes in the dentate nuclei after treatment

(a and b) Signal changes involving the dentate nuclei bilaterally (a and b) Resolution of the signal changes in the dentate nuclei after treatment

Discussion

Anti-VGKC antibodies have been implicated in a variety of neuronal hyper-excitability disorders including Issacs’ syndrome (acquired neuromyotonia), Morvan's syndrome (neuromyotonia with cognitive impairment, sleep disturbances and dysautonomia), and limbic encephalitis (encephalopathy, seizures, sleep disorder, hyponatremia, and signal changes in the medial temporal lobes on MRI).[1] Unusual symptoms like chorea and chronic pain syndrome have also been reported.[23] These antibodies have been documented in some patients with long-standing epilepsies refractory to conventional anti-convulsants though the causality is not proven.[4] Patients with limbic encephalitis with anti-VGKC antibodies typically have medial temporal lobe signal changes though lesions in claustrum and basal ganglia have also been reported.[56] It is now understood that anti-VGKC antibodies are not directed against the VGKC itself, but against other cell surface antigens that form part of the VGKC complex; the various known antigenic targets being leucine-rich glioma-inactivated protein 1 (LGI1, typically associated with limbic encephalitis and central nervous system hyper-excitability disorders), contactin-associated protein 2 (Caspr2, typically associated with peripheral nervous system hyper-excitability disorders), and contactin 2 (no known phenotype).[7] Additional undiscovered targets may be responsible in those who have anti-VGKC antibodies but are LG1, Caspr2, and contactin 2 negative. Unfortunately, our patient did not have testing for any of these targets which is available only on a research basis. However, it should be emphasized that neither the diagnosis nor the management of our patient would have been affected even if any of these targets were to be positive. Patients with encephalitis due to anti-VGKC antibodies have been documented to have had ataxia as one of the clinical features. However, none have been previously reported with abnormal cerebellar findings on MRI or with preponderance of cerebellar signs. On a cellular level, there is evidence to support rationale for dentate nuclei involvement. Although seen widely throughout the brain, certain subtypes of the potassium channels have a proclivity for the cerebellum and in particular the deep nuclei like the dentate.[89] Voltage-gated potassium channel subunits Kv3.1b and Kv3.3 have been localized within the dentate nuclei in animal models and are hypothesized to play a role in motor control.[9] Our patient expands the phenotypic spectrum of anti-VGKC antibody encephalitis.
  9 in total

1.  Immunotherapy-responsive chorea as the presenting feature of LGI1-antibody encephalitis.

Authors:  George K Tofaris; Sarosh R Irani; Binith J Cheeran; Ian W S Baker; Zameel M Cader; Angela Vincent
Journal:  Neurology       Date:  2012-06-27       Impact factor: 9.910

2.  Voltage-gated potassium channel antibody-associated encephalitis with basal ganglia lesions.

Authors:  A Hiraga; S Kuwabara; S Hayakawa; S Ito; K Arimura; K Kanai; T Yonezu; T Hattori
Journal:  Neurology       Date:  2006-06-13       Impact factor: 9.910

Review 3.  The role of Kv3-type potassium channels in cerebellar physiology and behavior.

Authors:  Rolf H Joho; Edward C Hurlock
Journal:  Cerebellum       Date:  2009-02-27       Impact factor: 3.847

4.  Antibodies to voltage-gated potassium and calcium channels in epilepsy.

Authors:  H J Marian Majoie; Mark de Baets; Willy Renier; Bethan Lang; Angela Vincent
Journal:  Epilepsy Res       Date:  2006-07-25       Impact factor: 3.045

5.  Voltage-gated potassium channel antibody-associated encephalitis with claustrum lesions.

Authors:  Akiyuki Hiraga; Osamu Watanabe; Ikuo Kamitsukasa; Satoshi Kuwabara
Journal:  Intern Med       Date:  2014       Impact factor: 1.271

6.  Chronic pain as a manifestation of potassium channel-complex autoimmunity.

Authors:  Christopher J Klein; Vanda A Lennon; Paula A Aston; Andrew McKeon; Sean J Pittock
Journal:  Neurology       Date:  2012-08-15       Impact factor: 9.910

7.  Subcellular localization of the voltage-gated potassium channels Kv3.1b and Kv3.3 in the cerebellar dentate nucleus of glutamic acid decarboxylase 67-green fluorescent protein transgenic mice.

Authors:  V Alonso-Espinaco; I Elezgarai; J Díez-García; N Puente; T Knöpfel; P Grandes
Journal:  Neuroscience       Date:  2008-07-12       Impact factor: 3.590

Review 8.  Autoimmune encephalitis: recent updates and emerging challenges.

Authors:  Sudarshini Ramanathan; Shekeeb S Mohammad; Fabienne Brilot; Russell C Dale
Journal:  J Clin Neurosci       Date:  2013-09-15       Impact factor: 1.961

9.  Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre.

Authors:  Ross W Paterson; Michael S Zandi; Richard Armstrong; Angela Vincent; Jonathan M Schott
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-06-11       Impact factor: 10.154

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.